Abstract: Genetic lesions causing human male infertility are manifold. Besides gross chromosomal aneuploidies and rearrangements, microdeletions and single gene defects can interfere with male fertility. Male fertility is not only dependent on genes controlling the male germ line but also on genes of the networks functional for male gonad development and male somatic development, respectively. It is popular to unravel these netweorks with mouse gene knock-out mutants displaying reproductive defects. However, substantial arguments can be given for more functional studies directly on the human genes, because multiple reproductive proteins evolve quickly most likely for adopting to the specific needs of the species class. Prominent examples are mutations of the FSHR gene causing different pathologies in mouse and human and the DAZ gene family not found in the mouse genome but in the human genome with an essential male fertility function. Therefore this review is focussed on a comprehensive overview of human genes known with mutations causing male infertility (AR; AZF gene families; CFTR, DM-1, DNAH gene family, FGFR1, FSHR, INSL3, KAL-1, LGR8-GREAT, LHR, POLG). Then some human genes are described well recognised as functional in spermatogenesis and male fertility although gene specific mutations causing infertility were not yet identified (CREM, CDY1, DAZL1, PHGPx, PRM-1, PRM-2). They are designated as "spermatogenesis phase marker" or "male fertility index" genes, because they are useful tools for diagnosing the patient´s´ spermatogenesis disruption phase and for predicting the presence and quality of his mature sperms. Current therapeutic protocols for human male infertility do usually not cure the specific gene defect but try to bypass it using Artificial Reproductive Technology (ART). Putative imprinting defects in the early embryo probably associated with the used ART protocol and an increase of chromosome abnormalities in the ART offspring now strongly asks for a significant improvement of this outcome requesting urgently more basic research on the genes functioning in the human male germ line and during early human embryogenesis.
INTRODUCTION
Human male infertility is a major health problem worldwide. Its prevalence in Western countries has been estimated with 20% [1] . Anatomic defects, endocrinopathies, immunologic problems, ejaculatory failures and environmental exposures are significant causes of infertility. Frequently, however, no clear cause for the observed infertility could be diagnosed coining the term "idiopathic infertility". At least in part, this is the result of our still poor understanding of the basic mechanisms regulating the genetic networks controlling male fertility, respectively, the molecular genetic of male infertility. It is assumed that in about 30 % of cases male infertility is caused by chromosome aberrations or mutations in genes functioning in the male germ line. From mouse and Drosophila knock out experiments it has been deduced that the products of more than 3000 genes are involved in the genetic control circuits regulating the expression of male (and female) fertility [2] [3] [4] . Thereby it become obvious that male fertility is not only dependent on the genetic network of the germ line but include the networks functional for male gonad *Address correspondence to this author at the Voßstrasse 9, D-69115 Heidelberg, Germany; Tel: +49-6221-567918; Fax: +49-6221-5633710; E-Mail: peter_vogt@med.uni-heidelberg.de development, and male somatic development. The presence of genetic switch signals have been proposed for linking these networks and/or for controlling them [5, 6] .
In human, the molecular identification of male fertility genes is hampered by the fact that human is not an experimental species. An infertile man is only recognised after the couple desiring for a child has asked for some therapeutic treatments in an infertility clinic [7] . Unfortunately, however, clinical examination of these couples only extends then to an analysis of their genetic conditions if the diagnose is "idiopathic infertility". A general overview of genetic defects causing male infertility is therefore restricted to only a subgroup of infertile man, although this subgroup is large with about 40%. However, it is unknown whether a general genetic analysis of all infertile men would not also influence the therapeutic protocol of some other patient groups.
Genetic lesions causing male infertility can be roughly grouped in three classes: (1) Chromosomal aneuploidies and rearrangements where batteries of genes on specific chromosomes have increased their expression dosage or changed their normal genomic environment; (2) submicroscopic deletions (i.e. microdeletions) where deletions or rearrangements of multiple genes mapped in a molecular neighbourhood have changed their normal expression pattern and (3) single gene defects where the expression of a single gene (also called key element) is changed or lost causing then male infertility.
CHROMOSOME ABERRATIONS WHICH CAUSE MALE INFERTILITY
Aneuploidies or structural aberrations are found in about 14% of azoospermic men (i.e., infertile patients with no spermatozoa in their semen fluid) and 5% of oligozoospermic men (i.e., infertile patients with a severe reduction in the number of spermatozoa in their semen fluid) [8] . Most chromosome abnormalities causing male infertility include one of the sex chromosomes, X and Y, whereby the karyotype 47,XXY associated with the Klinefelter syndrome is the largest homogenous group. Although Klinefelter patients are usually azoospermic, individuals with a low number of spermatozoa in their testicular tissue can be found frequently [9] and reports of Klinefelter´s who naturally fathered a child have been described in rare cases [10] . It is not yet known why Klinefelter patients are infertile, and why in about 20% of cases a mosaic karyotype, 46,XY/47,XXY is observed. But it has been speculated that the reduction of postmeiotic germ cells, generally observed in this patient group, is probably due to an interference of the pre-meiotic sex chromosomes´ pairing process where the second X chromosome would compete with the Y chromosome. Mouse animal models, however, suggest an interference in the male germ line already during fetal life [11] .
Klinefelter patients with increasing numbers of X chromosomes in their karyotype (48, XXXY; 49, XXXXY) shift their sexual phenotype to the female site. Penis development is reduced and cryptorchidism is found in most cases. This suggests an X chromosomal dosage effect on the males´ gonad development and that the balance of the sex chromosomes (X and Y) is crucial for this early embryonic process. Molecular isolation of a number of genes located and functional on both sex chromosomes (X and Y) have now provided first molecular support for this genetic balancer model " Fig. (1) ". Since the X homologues are not inactivated by the general X chromosomal imprinting process, their increased expression in men with a 47,XXY karyotpye is expected. A major testicular germ cell tumour (TGCT) susceptibility gene linked with an history of undescended testis, UDT gene, has recently been mapped to Xq27 [12] . This would point to an increased risk for Klinefelter patients to develop a testicular tumour if they had an history of undescended testis in their childhood.
Men with a double Y chromosome in their karyotype (47,XYY) also occur frequently (1:750) but their fertility status is variable. If infertile, they are usual oligozoospermic. Highly increased rates of YY bivalents observed during pachytene in the spermatocyte nucleus; 45-75% [13] suggests that also in this patient group the normal formation of the X-Y paring complex in their germ cells is inhibited and therefore a major source of their infertility.
The mosaic karyotype 45,X/46,XY leads to male infertility because of mixed gonad dysgenesis. It is found in infertile men with an incidence of 4%. They are recognized in the clinic by a streak gonad at one site and a dysgenic gonad at the other site. Outer genitalia might be normal or presented with micropenis, hypospadia and small testis volumes. The occurrence of also female phenotypes with the same karyotype points again to the delicate balance of developmental decision(s) towards the male or female sexual pathway in early embryogenesis. Although the Y chromosome had a normal size in this patient group, it lacks the fluorescent staining block after banding with quinacrin, usually marking the Yq12 domain in the distal part of the Y long arm. These "non-fluorescent" Y chromosomes (Ynf) were then found to have a breakage in Yq11 with subsequent fusion of a second Y chromosome also broken in Yq11 forming a dicentric iso-Yp chromosome " Fig. (2) ". Meiotic pairing of the Y to the X chromosome is inhibited because of self pairing of the iso-Yp between its doubled short arms [14] . This patient group therefore belongs to those with deletions of the Azoospermia Factor (AZF) in Yq11 (see below).
Men with azoospermia and the karyotype 45,X are also belonging to the AZF patient group " Fig. ( 2)". They have an unbalanced karyotype because the distal part of the euchromatic long Y arm (Yq11) is lost [15] . The other part of the Y chromosome including the SRY Gen locus is translocated to an autosome (most frequently to the short arm of one of the acrocentric chromosomes 13, 15, or 22) .
The impact of balanced Y-A translocations on male fertility is variable because the same karyotypes were observed in fertile and sterile men sometimes even in the same pedigree [16] . In most familial cases, the distal heterochromatic part of the Y long arm (Yq12) is translocated to the short arm of an acrocentic chromosome and the Y chromosome is broken in Yq11 [17] . This patient class therefore belongs also to the AZF patient group " Fig.  ( 2)". In two cases where an analysis of meiotic chromosomes was performed, it could be shown that the premeiotic X and Y pairing process is partly inhibited [18, 19] . Since the dynamic behaviour of this pairing process is known to be essential for the postmeiotic germ cell development [20] , it can be stated that the general intactness of the chromatin structure in Yq11 is part of a chromosomally based Y fertility factor linked to the AZF locus (see also below the chapter of AZF chromatin folding code).
Azoospermic men with a 46,XX karyotype are found less frequently (1:20000 newborns). Male sex and gonad development is normal because the distal part of the short arm of the Y chromosome (Yp11), including the sexdeterming region Y (SRY) locus, is translocated to the distal part of the short X chromosome arm (Xp22). Intersexual phenotypes (i.e. cryptorchidism, micropenis and hypospadia) are only observed when the X-Y-breakpoint-fusion-point is located in the neighbourhood of the SRY gene disturbing a timely activation of the SRY gene for male sex determination [21] .
Chromosomal aneuploidies and translocations between autosomes (Robertsonian and reciprocal) were found less frequent than sex chromosomal abnormalities although structural aberrations (translocations, inversions) are found 10 times more frequently in infertile men than in the fertile men population. Especially, pericentric inversions in chromosome 1, 3, 5, 6, 10 seem to interfere with meiosis leading to a reduced rate of postmeiotic sperm numbers or even azoospermia. In 60% of cases with Robertsonian translocations the two acrocentric chromosomes, 13 and 14, were involved [22] . Autosome aneuploidies like trisomies of chromosome 21 (Down syndrome), have individual effects on male fertility [23] .
THERAPEUTIC PERSPECTIVES FOR CHROMO-SOME ABNORMALITIES
Chromosomally based male infertility factors are most likely associated with variabilities of the meiotic cell division process. This can be visualised by the variable occurrence of asynaptic chromosome regions in the synaptonemic complex [24, 25] . It can be assumed that all chromosome abnormalities are generally counter-selected by the meiotic segregation mechanisms [26] . The chromosome abnormalities found in the patient´s lymphocytes need therefore not to be present in his postmeiotic germ cells. Therapeutic protocols for the treatment of chromosomally based male infertility must therefore include the confirmation of the patient´s lymphocyte chromosome aberration in his mature germ cells. Fig. (1) . Schematic view on current map of functional X-Y homologous genes. The Y-specific SRY gene is male sex determining, the Xspecific DAX1 and XH2 genes are testes and female sex determining, whereas the X-specific androgen receptor (AR) is a gonad-specific transcription factor functioning for male gonad development after binding androgens testosterone (T) and dihydrotestosterone (DHT), respectively. For further description of some single genes see text.
Fig. (2).
Seven typical chromosomal rearrangements in Yq11 which are associated with the occurrence of infertility, azoospermia or oligozoospermia because of disruption of the Y chromosomal AZoospermia Factor (AZF) [14] . Monocentric Y chromosome with breakpoint in long Y arm (A) Dicentric iso-Yp chromosomes (B) and ring-Y chromosomes (C) are often found together with a 45,X0 cell line in the patient´s lymphocyte nuclei pointing to the instability of the Y chromosome after these breakage events. Translocations of the Y chromosome broken in Yq are possible to the X chromosome (E) and to autosomes (F, G) (mainly the acrocentric chromosomes 14, 15, 21).
However, a high incidence of sex chromosomal aneuploidies has been observed repeatedly in sperm samples also when the patient´s sperm sample had a low morphological quality and the karyotype in lymphocytes was normal [27] [28] [29] [30] [31] [32] [33] [34] . This is because paternal nondisjunction of the meiotic chromosomes includes much more the sex chromosomes (X and Y) than the autosomes, whereas aneuploidies of chromosome 13, 16, 18, 21 occur more frequently by maternal errors during the first and second meiotic division of the maturing oocyte [35] . A normal chromosome complement in the patients´ lymphocytes can therefore not exclude an increased rate of aneuploidies in the postmeiotic germ cell.
By means of Fluorescence-In-Situ-Hybridisation (FISH) protocols it is now possible to analyse chromosome abnormalities in sperms directly [36] . A comprehensive analysis of the complexity of chromosome aberrations in infertile men would need a FISH protocol which paints each chromosome with a specific colour code [37] . However, in most cases DNA probes which mark distinct chromosome regions are preferred because the sperm chromatin is highly condensed and not-overlapping FISH spots for the analysis of single chromosome aneuploidies are requested. Sex chromosomes and chromosomes 1, 4, 6, 7, 8, 9, 10, 11, 12, 14, 16, 17, 18, 22 were analysed usually with FISH probes cloned from the chromosome specific alphoid repetitive sequence blocks in the centromeric regions of these chromosomes [38] . Chromosomes 13 and 21 are analysed with FISH probes generated from Bacterial-ArtificialChromosomes (BACs) cloned from specific chromosome regions (13q22 contig; 21q22.1 contig) [29] . FISH-labeling and detection kits including fluorochromes painting each chromosome with a specific colour code are now commercially available from different companies (e.g. Vysis; Oncor, Amersham).
An extensive FISH analysis on sperms of nine patients with severe oligoasthenoteratospermia (OAT syndrome) was performed by Pang et al. [29] using FISH probes specific for 14 chromosomes (4, 6, 7, 8, 9, 10, 11, 12, 13, 17, 18, 21 , X, Y). They found a high increase of chromosomal disomies (frequency range: 0-5,4%) compared with fertile control samples (frequency range: 0.05-0.2%). Also the frequency of diploid chromosomes in the sperms of their OAT patients was significantly increased (0.4-9.6%; controls showed a mean of 0.04%) and the total number of aneuploidies in sperms of the OAT patients was estimated with 33-74%. The mean total aneuploidy in spermatozoa of fertile controls ranged between 4.1-7.7%. All FISH germ cell studies report a significant increase of the aneuploidy rate of the sex chromosomes especially in men with OAT syndrome [33, 34] . This is most important for the therapeutic treatment of this patient group if one wants to apply artificial fertilisation technology (ART) with single sperms like ICSI (IntraCytoplasmic-Sperm Injection), which is not dependent on sperm morphology. Sex chromosome aneuploidies have a high risk to be transmitted to the offspring [39] .
A major therapeutical draw back of the FISH analysis of sperms is the fact that sperms treated with the FISH protocol and identified then with a normal set of chromosomes can not be selected subsequently for the IVF/ICSI therapy. Since it seems also not safe to identify sperms with chromosome aneuploidies by a specific morphology or decreased motility [40] , the risk factors for transfer of a specific chromosome anomaly to the IVF/ICSI offspring can only be based on a statistical evaluation of the patients´ sperm samples. Obviously, this is not satisfying and only reasonable for patients with large sperm numbers, but not for patients with severe oligozoospermia (<1 million sperms) or even azoospermia.
It has now been reported that sophisticated testicular tissue expiration protocols (TESE) are able to extract single sperms from testicular biopsies of azoospermic Klinefelter patients in more than 40% of cases [41] . Using subsequently ICSI for fertilisation of the partner´s oocytes, Klinefelter patients can now father a child. However, as expected these sperms have very often (but not always) an increased frequency of chromosomal aneuploidies [42] . Indeed, a man identified with a 14-fold higher frequency of XY disomy in his spermatozoa than in controls produced a 47,XXY fetus with Klinefelter syndrome after ICSI [43] . A high rate of the disomic sex chromosome (i.e. XY) constitution in germ cells therefore bears the risk of getting a son with the same infertility syndrome. Additionally, there seems to be also a risk for novel aneuploidies in offspring of Klinefelter patients, like trisomy 21 [44] . Trisomy of chromosome 21 is not sex-linked and causes a mental retardation syndrome in male and female offspring as well; also called Down´s syndrome (see website: http://www3.ncbi.nlm.nih.gov/htbinpost/Omim/dispmim?190685).
Since in a compromised testicular environment an increase of meiotic errors is expected in general [25, 45] , a FISH analysis on all chromosomes in the sperm nuclei would be the state of art, if one wants to minimise the risk of any chromosome aneuploidies in the offspring. Additionally, it would also help to reduce the risk for implantation failure or for an early abortion of the pregnancy due to some abnormal chromosome segregations in the early embryo. Most chromosome aneuploidies are embryonic lethal and only aneuploidies of the sex chromosomes and the chromosomes 13, 14, 16, 18, 21, 22 have a chance to be transmitted to the offspring. Therefore, markers for these chromosomes should be included first in any FISH probe cocktail.
Theoretically, a balanced chromosomal translocation in the lymphocytes of one parent has a risk of 50% to become unbalanced in the offspring. However, all chromosome abnormalities are generally counter-selected by the meiotic segregation mechanisms [26] , and translocation chromosomes are expected with a variable frequency in the postmeiotic germ cells. Robertsonian translocation chromosomes were found with a frequency between 3-27% for an unbalanced karyotype in postmeiotic germ cells by FISH and karyotype sperm analyses [32] . Therefore, although there is a general risk for an unbalanced karyotype in the patientsó ffspring, its individual frequency can only be identified by FISH in the germ cells of the patient directly. In case of a high frequency, preimplantation diagnosis (PGD) of the blastomere chromosomes is required screening for the same chromosome anomaly.
Structural chromosome aberrations can be analysed by FISH in spermatozoa, after the chromosome location of the genomic rearrangement has been mapped from the metaphase chromosomes of the patient´s lymphocytes. FISH probes are then designed according to the identified chromosomal breakpoint-fusionpoints with a breakpoint overlapping BAC clone extracted from the GenBank database. The complete human genome sequence is now deposited in the internet-web as an overlapping BAC sequence contig (see website: http://www.ncbi.nlm.nih.gov/genome/guide/human).
An attractive alternative of the FISH analyses on sperms would be a FISH on the patients´ meiotic chromosomes in pachytene spermatocytes extracted from the patientst esticular biopsies [46, 47] . A FISH sperm analysis may then not be needed because the risk for sperm chromosome aneuploidies can be deduced from the severity of the observed distortions in the meiotic chromosomes segregation pictures. Studies on meiotic chromosomes extracted from testicular biopsies would save all mature sperm cells for the subsequent ICSI treatments and therefore have a general benefit, especially for all those patients with a low sperm number and OAT syndrome [33, 34] .
From the first large comparative study of germ cell chromosome analyses with later prenatal chromosome analyses in the corresponding ICSI offspring, it has been now established that ICSI offspring have an increased risk for chromosomal abnormalities, especially for those with sex chromosomes. This risk seems to correlate with number and motility of the fathers´ germ cells and their frequency of chromosome abnormalities [39] . The same major outcome was also predicted from a large data collection of earlier germ cell chromosome studies [22] . Moreover, it is advisable to include a preimplantation diagnosis (PGD) for any case with a significant risk of sperm cell chromosome aneuploidies, like patients with Klinefelter syndrome. PGD offers the couple to choose then a female embryo or male embryo with a normal karyotype for subsequent implantation. A later prenatal diagnosis with the option of abortion can be a second option.
MOLECULAR ABERRATIONS WHICH CAUSE MALE INFERTILITY
From mouse knock-out models it has been predicted that more than 3000 genes expressed in the male (and female) germ line cause infertility or at least subfertility [3, 4] . However, although most of their human homologues are known, it is often unclear whether and how these genes are functional in the human male germ line. When rodent and human gene sequences are compared, many reproductive genes are found among the 10% most divergent gene sequences [48] which indicates a rapid evolution of just reproductive proteins [49] . Consequently, it must be questioned, whether functional human spermatogenesis studies should be not better carried out directly with the human male fertility genes? However, the common mutation rates of human genes have been estimated to be in the range of 10 -4 -10 -6 [50] and that is certainly also true for the male fertility genes. Accordingly, for most of the putative human male fertility genes where mouse homologues exist and where knock-out mutants have displayed a reproductive disorder, it is not yet known how frequent the human genes are mutated in the large group of patients with idiopathic infertility, despite two notable exceptions: Deletions of the AZoospermia Factor (AZF) genes located on the long arm of the Y chromosome (Yq11) and mutations in the Cystic Fibrosis (CF) locus located on the long arm of chromosome 7 (7q31.2). AZF gene deletions are found most frequently in patients with non-obstructive azoospermia [51, 52] , whereas CF mutations are abundantly found in patients with a congenital aplasia of the vas deferens (CBAVD), i.e. with obstructive azoospermia [53] . Molecular genetic research on human male fertility genes is therefore often only practical for those genes with a high mutation rate, since human is not an experimental species.
THE AZF LOCUS IN YQ11
Most Y chromosomal rearrangements with a breakpoint in Yq11 have been associated with distortion of male fertility " Fig. (2) ". This suggested a spermatogenesis locus in this Y region already 27 years ago [54] . Because the sterile pheno-type observed in these patients was mostly azoospermia, this locus was designated as AZoospermia Factor (AZF). Molecular deletion mapping in Yq11 has then subdivided AZF in three spermatogenesis loci (AZFa, AZFb, AZFc) " Fig. (3A) ". Their deletion interrupted spermatogenesis at three different phases [15] . A complete Sertoli-cell-onlysyndrome (SCO) is observed in patients with deletion of AZFa, i.e. only Sertoli cells, but no germ cells are visible in the tubules of their testis tissue sections Arrest at the spermatocyte stage is observed in the testis tissue of all patients with deletion of the complete AZFb locus (AZFb). The populations of spermatogonia and primary spermatocytes in all tubules analysed are normal, however, no postmeiotic germ cells have been identified A variable testicular pathology has been found in patients with AZFc deletions in distal Yq11. In most tubules only Sertoli cells are identified but in some tubules germ cells of different developmental stages are clearly visible " Fig. (3B) " and the occurrence of mature sperm cells albeit in a low number has been also reported from different laboratories [55, 56] . Hypospermatogenesis seems therefore to be the primary result of an AZFc deletion [51] and it is not surprising that AZFc deletions can also be inherited from father to son although only in rare cases [56] [57] [58] [59] .
It has been also argued that the patient´s AZFc deletion does not cause his infertility [60] . More likely this would be a polymorphic deletion event present in the patient´s family. However, most AZFc deletions are found as "de novo" mutations, i.e., being restricted to the patient´s Y chromosome and not present on the Y chromosome of other family members, which would be expected if the deletion would have a polymorphic origin. Consequently, AZFc deletions must be causative agents of the men´s infertility. They occur in different populations with a frequency of 10-20% [51, 52, 61, 62] and are therefore now acknowledged as the most common known genetic lesion found in men with non-obstructive azoospermia or severe oligozoospermia.
It has been shown that microdeletions on autosomes are caused by local recombinations between repetitive homologous sequence blocks [63] and this is also the case for the AZF microdeletions on the human Y chromosome. Analysis of the complete Y sequence, now published in GenBank database [64] has revealed that the Yq11 part of the long arm is largely composed of Y-specific repetitive sequence blocks especially in the AZFc deletion interval [65] . Intrachromosomal recombination events between repetitive specific HERV (Human Endogenous Retroviral) sequence blocks are now known as the major cause of AZFa deletions [66] [67] [68] and the molecular extension for complete AZFa deletions has been estimated with 782 kb. Similarly, recombinations between large homologous sequence blocks composed of different repetitive sequence families are the major cause of complete AZFb and AZFc deletions and their molecular extension is estimated with 6.2 Mb (AZFb) and 3.5 Mb (AZFc), respectively [65, 69] "Fig. (3C) ". Whereas the AZFb deletion interval also contains a large sequence block with normal euchromatic sequence complexity (designated as u1: ~3Mb), about 94% of the AZFc sequence complex are covered with unusually large repetitive sequence blocks. They are called amplicons [65] with variable length, between 115 kb (grey amplicons) and 700 kb (yellow amplicons) and explain the high mutation rate for the AZFc locus in distal Yq11.
Most intriguing is the structural assembly of these large repetitive sequence blocks in 5 palindrome structures (P1-P5) in the AZFb and AZFc deletion intervals " Fig. (3C) ". In distal AZFc, the 3 Mb large palindrome structure (P1-palindrome) which covers two-third of the complete AZFc deletion interval is constituted of 5 different amplicons " Fig.  (3C) ". The sequence homology of the palindrome arms is >99.9% [65, 69] . The distal part of the AZFb deletion interval and the proximal part of the AZFc deletion interval are overlapping and the 4 palindromes P2-P5 are mapped, from distal to proximal (towards the Y centromere) in distal AZFb (P2: 270 kb, P3: 730 kb) and in proximal AZFb (P4: 380 kb P5: 900 kb) respectively " Fig. (3C) ". Palindromic DNA structures are rare in eukaryotic genomes because of their inherent instabilities [70] . Consequently, local homologies between repetitive sequence blocks in P1 and the P5 palindromes in proximal AZFb have led to most AZFb deletions " Fig. (3C) ". It is important to recognise that patients with deletions of the AZFb plus AZFc interval have not deleted the complete AZFc sequence as defined by Kuroda-Kawaguchi et al. but their AZFc deletion ends in the distal arm (P1.1) of the P1 palindrome " Fig. (3C) ". Its molecular extension was estimated with 7.7 Mb [69] . AZFc deletions are caused by homologous recombination between the 229 kb long b2 and b4 amplicons [69] although one may speculate that the large P1 palindrome is also actively involved in the creation of these recombination events.
The genomic DNA of each AZF deletion interval contains multiple genetic elements which are probably functional parts of the AZF locus. Extensive testes cDNA screening programs [71, 72] , and the structural analysis of the the GenBank AZF sequences (AZFa and AZFb in contig: NT_011875; AZFc in contig: NT_011903) by predictive gene analyses programs have identified the putative complete gene content of each AZF microdeletion. 32 Y genes expressed in human testis and located in one of the AZF deletion intervals are registered. They are subdivided in Table 1 in a list of genes with a recognizable function because of one or more conserved functional peptide domains (Table 1A ) and in a list of genes with non-identified function because similar sequences have not yet been found in the data base (Table 1B) . AZFa contains 2 Y genes: USP9Y and DBY, and it might include functionally the UTY gene mapped closely to the distal AZFa HERV border line because the same gene triplet has been found structurally conserved on the mouse and cat Y chromosomes [73] . AZFb which overlaps with the proximal part of AZFc contains 23 putative functional Y genes [69] : 16 Y genes were mapped in the unique AZFb interval: CDY2, CYorf14, CYorf15A/B, EIF1AY, HSFY, PRY, RBMY1, RPS4Y2, SMCY, TTY5, TTY6, TTY9, TTY10, TTY13, TTY14, XKRY ( Table 1) . The Y genes designated with a CYorf symbol are coding proteins with unknown functions whereas the genes designated with a TTY symbol are declared as putative RNA coding genes because their exon sequences apparently have no significant open reading frame [71] . 3 AZFb genes (CDY2, RPS4Y2, XKRY) have more copies also proximal to AZFb and the 7 AZFb genes which are located in the [56] . Interval D25 correspond to the Yq12 heterochromatin. The D intervals deleted in infertile patients with complete AZFa, AZFb, and AZFc deletions are drawn with a specific colour code below the interval map. In contrast to the first AZF interval map in Vogt et al. [56] , molecular sequence analyses have now revealed a large overlap of the AZFb and AZFc deletion intervals [69] , and AZFb deletions extend approximately until interval D21. (B): Examples of the associated testicular pathologies are displayed below the AZF deletion map. Patients with complete AZFa deletions have always a complete absence of germ cells Patients with complete AZFb deletions usually show a meiotic arrest at pachytene whereas patients with complete AZFc deletions display a variable picture with a "mixed atrophy" in their testis tubules. Most tubules have a SCO, but some tubules contain also germ cells at different phases of differentiation. (C): Comparative view on the schematic AZFb and AZFc deletion intervals with their underlying genomic sequence structure now revealed by Kuroda-Kawaguchi et al. [65] and Repping et al. [69] . Molecular extensions of the estimated AZFb, AZFc and AZFb plus AZFc deletions are given in Mb. The five possible palindromic structures P1-P5 in this Yq11 region are marked each with the extensions of both arms below the amplicon structure in a similar colour code as used for the corresponding amplicons. Only the large P1 palindrome and the P3 palindrome include more than one amplicon type. The AZFb deletion overlaps with the AZFc deletion as indicated. The putative AZFb break and fusion points are marked by yellow arrows because they are mediated by recombinations between the homologous yellow amplicons, yel1, yel3 and yel4, respectively, in the first (P1.2 arm) and fifth palindrome (P5.1 and P5.2 arm). AZFc break and fusion points are marked by blue arrows because they are mediated by recombinations between the blue amplicons, b2 and b4. In patients with an AZFb plus AZFc deletion the distal breakpoint was found to be not in the b4 amplicon (as expected) but in the yellow amplicon yel2 (P1.1 palindrome arm) [69] . It has been reported that also men with AZFa and AZFb deletions present a variable testicular histology [74] [75] [76] . However, the molecular extensions of these Y deletions are now known to be not comparable with that of the originally defined AZFa and AZFb deletion intervals [56] and in cases where a re-analysis was possible only partial AZFa and AZFb deletions have been identified [61, 67, 77] .
Interestingly, all AZFa genes and most AZFb genes have an X chromosomal counterpart, and some of them are conserved on the mouse Y chromosome (Dby, Smcy, Rbm, Uty, Usp9y). However, so far analysed their function in mouse spermatogenesis looks different from that in human spermatogenesis. In mouse, Usp9y is expressed in brain and testis tissue [78] , whereas the human homolog USP9Y is expressed in all tissues analysed [71] . In mouse, deletion of most Rbm genes does not cause male infertility but only some sperms dysmorphologies [79] . In human, RBM genes are expressed during meiosis and their deletion causes meiotic arrest [80] . In mice with deletion of the Spy locus (mapped in the Sxrb interval of the short Y arm), expression of the Eif2y gene restores the proliferation phase of spermatogonia suggesting that Eif2y is the functional gene of the Spy locus [81] . In human, there is no homologous EIF2Y gene on the Y chromosome. It is therefore assumed that the human AZFa and AZFb genes and their homologous counterparts on the mouse Y chromosomes are functionally related but not orthologs in the male germ line of both species, i.e., their spermatogenic functions are divergent, respectively, adopted to the species specific needs, although most likely part of the same functional genetic network [82] .
The AZFc locus can be considered as an evolutionarily very young human spermatogenesis locus because no AZFc gene family has been found on the mouse Y chromosome. The DAZ gene family has been transposed from the DAZL1 locus on chromosome 3 (3p25) to the Y chromosome after divergence of the Old world monkey line of primates, i.e., not before about 35 million years ago [83, 84] . The CDY gene family originates from a polyadenylated mRNA of the CDYL locus on chromosome 6 which has been then retrotransposed to the Y chromosome also first after divergence of the Old world monkey line of primates [85] .
Do AZF Gene Mutations Cause Male Infertility?
It is still an open question whether infertility is caused in men only after deletion of the complete gene content in one of the AZF loci, or also after deletion or dysfunction of a specific AZF gene as well. Until now, an AZF gene mutation probably associated with the occurrence of male infertility has been only found for the USP9Y gene in AZFa. After sequence analysis of the USP9Y sequence in 564 patients with azoospermia or severe oligozoospermia, a 4bp deletion as part of the splice-donor site of exon 8 was identified as "de novo" mutation in one patient with spermatid arrest [86] . This suggests a functional contribution of USP9Y to human spermatogenesis. However, the AZFa pathology, is a complete SCO syndrome. Expression of the DBY gene or other genetic factors in AZFa must therefore also contribute to the AZFa spermatogenic function.
A similar situation might be present in AZFb where partial proximal AZFb deletions not including the PRY and RBMY gene loci but proven to be "de-novo" deletion events were associated with hypospermatogenesis [77] , whereas complete AZFb deletions cause a complete meiotic arrest. However, since also a SCO and natural transmission was described for some of the partial-AZFb patients [77, 87] , impairment of the testicular function in this patient group seems variable and reflecting some linkage with other spermatogenesis genes located on different still unknown chromosomal sites. Gene-specific mutations in the RBMY gene locus were found in fertile men and infertile men, revealing a polymorphic number of pseudogenes in this AZFb gene family [88] .
Specific mutations in a gene of the AZFc gene families are difficult to map because the multiple copies of all AZFc genes have an extremely high sequence homology >99.9% [65] . A functional difference between genes mapped in proximal and distal AZFc, respectively, might be indicated by the work of Fernandes et al. [89] , who found deletions of the DAZ1/DAZ2 gene doublet in proximal AZFc only in men with severe oligozoospermia, but DAZ3 and DAZ4 deletions in men with normal fertility as well. It could be shown that these proximal AZFc deletions are caused by recombinations between the g1/g2 amplicons in AZFc " Recently, some peptides encoded from AZFa and AZFb genes (USP9Y, DBY, UTY, and SMCY) were identified as putative male specific minor histocompatibility antigens (H-Y antigens) recognised from gene products encoded in different classes of the large Major Histocompatibility Locus (MHC) on the short arm of chromosome 6 (3.6 Mb in 6p21.3) [91] : the HLA-A1 class (USP9Y) [92] , the HLA-DQ5 class (DBY) [93] , the HLA-B8 and -B60 class [UTY; 94, 95] and the HLA-B7 and -A2 class (SMCY) [96, 97] . Indeed, the influence of some H-Y antigens on human (and mouse) testicular organisation and spermatogenesis has long been predicted [98] and molecular deletion mapping has localised an H-Y antigen locus on the human Y chromosome in the proximal part of the long Y arm [99] overlapping with the AZFa and AZFb intervals " Fig. (3A) ". The only receptor for H-Y antigens was identified in the membranes of Sertoli cells [98] and their expression revealed in early embryogenesis [100] . Y chromosomal H-Y antigens might therefore be considered as early male-specific cell markers probably contributing as positive signals for the first steps of male sexual and germ line development during early embryogenesis. Whether the deletion of any of those linked to the Y genes in AZFa and AZFb are associated with the occurrence of male infertility is difficult to assess but can also not be excluded.
ICSI Transmission of AZFc Deletions can Cause Severe Gonadal Dysgenesis in Offspring
Using sperms of AZFc patients in ICSI a 100% transmission of the AZFc deletion to the male offspring has been reported [101] [102] [103] . That means the sons of AZFc patients will become infertile as well. However, additionally, there seems to be a risk for AZFc offspring to get some forms of gonadal dysgenesis or even sexual reversal as well. There is some growing evidence that the complete loss of the Y chromosome causing embryonic 45,X0 cells is triggered by AZFc deletions as premutations. So a variable percentage of a 45,X0 cell line was found commonly associated with AZFc microdeletions [104, 105] . This is similar to the occurrence of patients with a cytogenetically visible iso-Yp chromosome where the Yq11 breakage-fusion events also have deleted the AZFc and most of the AZFb interval. A mosaic 45,X0 cell line occurs frequently in the karyotypes of this patient group as well " Fig. (2) ". Indeed, a man with ambiguous genitalia, 45,X/46,XY mosaic karyotype and AZFc deletion has been already reported [106] . Now screening the Y chromosome of 12 patients, who had a 45X/46XY karyotype and presented with Turner stigmata and sexual ambiguities a high incidence of AZFc deletions was found in this patient group as well [107] . In an international survey of prenatally diagnosed 45X/46XY mosaicism a wide spectrum of phenotypes, including Turner syndrome, mixed gonadal dysgenesis, male pseudohermaphroditism, mild mental retardation, autism, but also normal men have been reported [108] . Therefore, it is wise to offer couples where fathers had an AZF microdeletion a prenatal diagnosis (PGD) for revealing a putative mosaic 45X/46XY karyotype in the fetus as early as possible.
THE CF-LOCUS IN 7Q31.2
In contrast to the AZF locus, the functional picture of the CF (Cystic fibrosis) locus is much more elucidated. The locus encodes the Cystic Fibrosis Transmembrane conductance Regulator (CFTR) gene which is functioning as a lowvoltage, cyclic-AMP-regulated transmembrane channel for chloride ions [109] . The CFTR protein is a member of the ATP-binding cassette (ABC) familiy of transporter proteins. CFTR gene defects cause cystic fibrosis (CF) which is mainly characterised by persistent Pseudomonas aeruginosa colonization of the conducting airways. CFTR gene mutations were divided in 6 classes (I-VI) and two major categories. The first category includes those mutants where the CFTR protein is unable to accumulate at the cell surface, either because of impaired biosynthesis (Class I and V), or because of defective folding at the endoplasmic reticulum (Class II). Mutants that belong to the second category express the CFTR protein at the cell surface but its mutated structure fails to translocate chlorid ions because of a defect in activation (Class IV). CFTR class VI mutants appear to be normal in their biosynthetic processing and macroscopic chloride channel function but the biological stability of the mature, complex-glycosylated form is dramatically reduced [110] . Most frequently found in many populations (although not in all) is a deletion of 3 nucleotides in exon 10 which results in the loss of a phenylalanine residue at position 508 of the putative CFTR protein [111] .
According to the CFTR online database (http://www. genet.sickkids.on.ca/cftr) a surprisingly high number of 1005 pathological CFTR mutations and 208 variants are registered, although most of them are rare and only present in single families. This suggests that the CFTR gene sequence can accommodate a certain variability without loss of his basic function: a protein with chlorid channel activity in the membranes of epithelial cells. It also indicates that the CFTR protein is embedded in a complex genetic network because the severity of the CF pathology associated with a specific gene mutation is variable in different pedigrees [112] . Depending on the CFTR mutation, the somatic disease phenotype is variable from severe pulmonary disease with pancreatic insufficiency to chronic bronchiectasis [113] . The high rate of heterozygous CFTR mutations in populations even suggests a functional benefit for at least some CFTR mutations. Indeed, it has been shown that cells expressing wildtype CFTR internalized more Salmonella typhi than isogenic cells expressing the most common del-F508 CFTR mutation [114] . Obviously, diminished levels of the CFTR protein in heterozygotes is of benefit because it decreases the susceptibility to typhoid fever.
Most common are CFTR mutations which manifest their cystic fibrosis pathology not only in somatic cells but also as a congenital bilateral aplasia of the vas deferens (CBAVD) in male gonads [53] . In this large patient group the transport of the mature spermatozoa through the testicular and epididymal structures is blocked [114] . The absence of the vas deferens and variable portions of the epididymis is most likely caused by excessive mucus secretions in the epididymal lumen which eventually then leads to a progressive obstruction of the deferent ductal system, i.e., the viscous epididymal fluid impairs the proper development of the epididymis, vas deferens and seminal vesicles [116] . The pathology of obstructive azoospermia occurs with about 30% in the group of patients with azoospermia, and of those 25% suffer from CBAVD.
CFTR mutations have usually only a recessive 1 effect in somatic tissues [112] . In the germ line a dominant mutation effect is found, since only a small reduction of functional CFTR transcripts already causes male infertility [112] , Consequently, it can be predicted that also a CBAVD patient group without the somatic CF pathology but with CFTR mutations must exist as well. The epithelial cells in the male genital tract appear to be more sensitive to a quantitative CFTR protein deficiency than the same cell type in other organs and also the processing of CFTR mutant transcripts might be different in the two cell types [117] .
The most frequent CFTR mutation not causing CF but CBAVD is the 5T allele in the 3´splicing region of intron 8 [118] . In this region three T alleles (5T, 7T, 9T) have been diagnosed. The reduction of the number of Ts results in reduction of the efficiency of splicing exon 9 in CFTR mRNA " Fig (4) ". In the presence of the 5T allele only 10-40% of CFTR mRNA contains exon 9. Exon 9 encodes part of the functionally important first nucleotide binding domain.
CBAVD is diagnosed in 1.5% of all cases of male infertility and a remarkable number (60%) of heterozygous mutations in the CFTR gene form "compound heterozygotes" in the CBAVD patient group, i.e. different mutations in each gene copy are analysed [119] . Compound heterozygotes of CBAVD patients with a 5T allele in one gene copy and a Arg117-to-His117 (R117H) mutation in exon 4 of the second gene copy have a severe CF phenotype, whereas the 7T allele would only result in CBAVD [117] .
Men with CBAVD have the 5T allele with a high frequency (84%). This suggests that with this mutation numerous compound heterozygotes must exist expressing the CBAVD pathology. These were indeed found with some of the highly polymorphic sequence variants (TG) m linked to the heterozygous M470V mutation [120] . Both variants have no deleterious consequences for the production of CFTR mRNA but in combination with the 5T allele the presence of these variants result in a high production of CFTR mRNA without exon 9 then causing the CBAVD pathology [121] . Probably there exists a general different processing of CFTR transcripts in the germ line since a higher proportion of CFTR-transcripts without exon 9 in vas deferens cells was also found independent of the T n genotype [122] .
Since male and female carriers of a CFTR mutation are found very frequently in different caucasian populations (1:25) , the female partners should be also analysed for a heterozygous CFTR mutation, after a CBAVD patient with a heterozygous or homozygous CFTR mutation has been identified. A heterozygous CFTR mutation in the female partner (carrier status), would predict a high risk (of at least 25%) for the occurrence of a severe somatic CF pathology in the IVF offspring. Heterozygotic CFTR mutations are easily analysed by the amplification refractory mutation system (ARMS) which allows to distinguish the normal and mutant CFTR allele in parallel by a PCR based technology [123] . Alternatively, the low but measurable ectopic transcription rate of CFTR mRNA in lymphocytes can be used to identify CFTR mutations at the transcript level [124] .
For the management of CFTR diagnostic quality control an European Network for cystic fibrosis genetic mutation analysis has now been established [125, 126: www. mwd.kuleuven.ac.be/cme/cf/genetic_diagnostic_labs.htm].
It has been reported that patients with obstructive azoospermia carrying a CFTR mutation had also significant lower seminal volumes (1.5+/-1.4 ml vs 2.8 +/-2.2 ml), lower pH values (6.8 vs 7.9) and a lower fructose content (1-4 vs 6- 83 micromol/ejaculate) than those without these mutations [127] . The analyses of seminal plasma markers therefore provides an effective and non-invasive method to predict CFTR mutations in men with obstructive azoospermia also from their ejaculates.
MORE GENE MUTATIONS INTERFERING WITH HUMAN SPERMATOGENESIS
The number of human genes with mutations causing impairment of spermatogenesis is still small ( Table 2) (KS) and Globozoospermia, i.e., caused by mutations in different genes.
Less known in the clinic are mutations in the INSL3 and LGR8-GREAT genes causing cryptorchidism, mutations in the DM-1 gene causing male infertility associated with the autosomal dominant dystrophica Myotonica (DM) syndrome, and the (CAG)-variants of the mitochondrial DNA polymerase (POLG) locus associated with male infertility. The clinical phenotypes of all syndromes associated with male inferility and with a distinct profile of inheritance are described in detail in Victor McKusicks´s "Mendelian Inheritance in Man (MIM)", respectively online (OMIM), under the given OMIM reference numbers (http://www3. ncbi.nlm.nih.gov/omim/).
ANDROGEN RECEPTOR GENE (AR) LOCUS
The androgen receptor (AR) gene is a member of the large intracellular family of glucocorticoid receptors which Production of testosterone (T) begins at the eighth week of pregnancy in fetal Leydig cells initiating the development of the male gonad from the Wolffian ducts. This includes formation of the epididymis, vas deferens, and seminal vesicles. Formation of the male external genitalia (penis, scrotum) requires the dihydrotestosterone converted from testosterone by the steroid 5α-reductase 2 (SRD5A2). The androgen receptor gene is not expressed in germ cells but in Sertoli cells at different phases [128] supporting its role in the coordinate promotion of male specific gonad and germ line development. After ligand binding the protein dimerizes and translocates to the cell nucleus where it binds to specified palindromic DNA elements (5´-TGTTCT-NNN-AGAACA-3´) defined as ARE (androgen responsive element) sites. Binding to a number of nuclear co-activators [129] the dimerized AR protein promotes the transcription of multiple target genes. The AR interacting proteins are listed in a database (http://ww2.mcgill.ca/androgendb/ARinteract. pdf).
The androgen receptor protein has a long N-terminal peptide domain (555 amino acids) encoded by exon 1 " Fig.  (5) ". This functions as transactivation domain (TAD) by modulating the transcriptional activity of the AR-dependent downstream genes. Exons 2-3 encode the peptide domain, 556-623, responsible for DNA binding (DBD) and exons 4-8 encode the C-terminal peptide domain, 624-915, responsible for androgen-binding (ABD). In addition to these prinicipal functions all 3 domains embody subsidiary functions that affect dimerisation, nuclear localisation and transcriptional regulation.
The TAD region in exon 1 is variable in length encoding a repetitive tract of glutamines (coded by CAG n ; n=9-36) and of glycins (coded by GGC n ; n=16-27). This polymorphism regulates quantitatively AR promoter activity which is enhanced with lower and reduced with higher numbers of the CAG-repeat [130] . Whether lower AR transactivation values would also impair the rate of spermatogenesis is still an open question [131] [132] [133] . In a large comparative study including 600 fertile and 674 infertile men from Europe no statistical different numbers of CAG-repeats were found in the fertile and infertile men group [134] and this was confirmed in other studies with 119 infertile men of Caucasoid origin [135] and 280 men from an Indian population [136] . However, probably ethnically differences exists for the functional phenotype of the TAD peptide activating downstream spermatogenesis genes in some other human populations.
It this context it is interesting to note that CAG repeat length above N=38 are associated with the occurrence of a severe neurodegenerative disease, Spinal Bulbar Muscular atrophy (SBMA: Kennedy syndrome: OMIM-ref: 313200). This syndrome is characterized by progressive degeneration of anterior motor neurons and a late onset of mild androgen resistance (MAIS). The SBMA CAG disease alleles range between N=38-62 [135] . This unusually large extension of Fig. (5) . Schematic view on the exon structure of the human Androgen Receptor (AR) gene with its 3 functional domains. The AR gene is located on the long arm of the X chromosome (Xq11-12) along 90 Kb. The first exon encodes the transactivation domain (TAD) forming the active gonad-specific transcription factor complex by binding with a series of other transcription factors. It has a polymorphic length due to two repetitive triplets (CAG) n and (GGC) n with variable n-values. Above the n value of 38 for the CAG repeat, the androgen receptor becomes a causative agent for Spinal Bulbar Muscular Atrophy (SBMA) a severe neuro-degenerative disease. The androgens testosterone (T) and dihydrotestosterone (DHT) are the ligands binding to the androgen binding region (ABD) encoded by exon 4-8. Specific point mutations associated with male infertility were found in the TAD and ABD region, respectively. The DNA binding region (DBD) of the AR protein has been mapped to exon 2 and 3. the polyglutamine tract in the AR gene is the causative agent for this neurodegenerative disease. Surprisingly, however, despite these large CAG tracts many SBMA patients are not infertile. Therefore, it must be questioned whether a higher number of the CAG-repeat in the TAD domain can cause male infertility like it cause the SBMA syndrome. Nevertheless there is no doubt that androgens contribute to the initiation and maintainance of the formation of spermatozoa. The androgen-receptor gene must therefore be also involved in the regulative genetic network controlling spermatogenesis.
The general high grade of sequence variations in the AR gene (more than 300 point mutations in the AR-database: http://ww2.mcgill.ca/androgendb/AR23C.pdf) reflects a high structural flexibility of the dimeric AR-protein in its functional complex with the multiple co-activators together then resulting in a gonad-specific transcription factor. Consequently, no specific pathology is found for most AR gene mutations but more a variety of pathological phenotypes ranging from testicular feminisation with male infertility (CAIS: complete androgen insensitivity syndrome) to only male infertility with a mild androgen insensitivity (MAIS). This variability is the consequence of the quantitative gradient of the T/DHT binding efficiency in the ABD region of the AR protein " Fig. (5) ". Mutation analysis of the AR gene should therefore be offered to all patients where male infertility is associated with a mild androgen resistance syndrome like Rosewater-Syndrome and Reifenstein-Syndrome (OMIM-ref. 312100, 312300).
Most AR gene mutations are missense point mutations. Mutation analysis must therefore be carried out directly by nucleotide sequence analysis. Specific point mutations associated with male infertility were found in the TAD and ABD region of the AR gene [138] . A M886V mutation found in 3 patients with severe oligozoospermia and a N727K mutation found in one patient both reduced the transactivation activity of the AR protein due to a reduced interaction with the TIF2 co-activator in the ABD region and the TAD region [138] . A clear therapeutic perspective for these patient´s infertility is given by administration of the androgen analogue, mesterolone [139] .
In cases where an increased length of the CAG repeat in AR exon 1 has been identified in the infertile patient, it is advisable to exclude the risk of transmission of Kennedy syndrome to the patient´s daughter before applying IVF/ICSI. For this purpose a DNA sample extracted from the patient´s sperms is needed to carry out a CAG-repeat pattern analysis in his germ cells [140] . Although it is expected that the SBMA risk is low when long CAG repeats were not found in the AR gene of his fertile brother or father [140, 141] , this risk would become significant when the CAGrepeat number in the patient´s sperm DNA would increase beyond the so-called pre-mutation value (n>33) then inducing the SBMA disease in his female IVF/ICSI offspring.
FOLLICLE-STEROID HORMON-/ LUTEINZING HORMON RECEPTOR (FSHR/LHR) LOCUS
The receptors for the gonadotropins Follicle-steroid hormone (FSH) and Luteinizing hormone (LH) belong to the family of G-proteins coupled receptors. They are characterized by a large extracellular domain that binds specifically the LH or FSH heterodimers. A α-helical 7-times plasma membrane piercing transmembrane domain links it to the intracellular domain which is coupled to the cellular G-protein signal pathway converting ATP to c-AMP via the adenylcyclase enzyme complex. Upon extracellular ligand binding (FSH or LH) conformational change of the intracellular receptor protein domain leads to the binding of G-proteins [142] . This structural relationship indicates a common origin of both genes (designated as FSHR and LHR) and a functional relationship. This also gained support by their clustered localisation on the short arm of chromosome 2 (2p21) and their related exon structures. The extracellular domain is encoded by exon 1-9 (FSHR) and exon 1-10 (LHR) respectively. The transmembrane, as well as the intracellular domains, are encoded in both genes by the long last exon (1251 nt in FSHR; 1200 nt in LHR).
Surprisingly, a variable suppression of spermatogenesis and fertility was diagnosed in men homozygous for the inactivating A189V mutation in exon 7 of the FSHR gene [143] . This questioned the essential role of FSH and FSHR expression for the initiation of spermatogenesis in human. Although FSH/FSHR action is required to increase testicular size, spermatogenesis can occur in the presence of severe FSH resistance as long as there is a normal production of testosterone. These observations have been confirmed recently in FSHR and FSH knockout mice [144] . Three single nucleotide polymorphisms (SNP) of the FSHR gene, one in the promoter region and 2 in exon 10 had also no influence on male fertility despite a significant correlation between these polymorphisms and the basal FSH levels have been diagnosed in females [145] .
Mutations in the LHR gene leads to hypogonadal phenotypes (Leydig cell hypoplasia, LCH) because of a delay in fetal and pubertal male development (male pseudohermaphroditism, MPH). MPH can be caused by different genetic anomalies. Among them are anomalies of the Leydig cell differentiation pathway causing hypoplasia or even absence of the Leydig cell (LCH). A number of mutations in the LHR gene resulting in complete or partial resistance to LH and associated with variable pathologies of the male gonad have been reported [146] . Male infertility then occurs because of male gonad dysgenesis including micropenis and hypospadias.
Familial male-limited precocious puberty (FMPP) has been diagnosed in patients with a constitutive activation of the LH transduction pathway [146] . It is a dominant disorder which is caused by two LHR mutations (D578G and M571I) located in the 6 th transmembrane domain [147] . The most severe phenotype resulting from altered LH-LHR interaction is characterized by an external female phenotype with a blind ending vagina and primary amenorrhoea. In summary, the variance of pathological phenotypes associated with LHR mutations is similar as has been found with mutations in the androgen receptor gene (see above).
Male infertility as the consequence of mutations in the gonadotropins themselves is rare. FSH and LH are heterodimeric molecules that share a common α-subunit (also with chorionic gonadotropin, CG and thyroid-stimulating hormone, TSH) and have specific β-subunits. The single gene encoding the common α-subunit has been mapped to chromosome 6 (6q12-21). The FSH-β subunit encoding gene has been mapped to chromosome 11 (11p13), the LH-β subunit encoding gene to chromosome 19 (19q13.32) where it is linked with six copies of the human CG gene. FSH is essential for Sertoli cell proliferation and maintenance of sperm quality in the testis. The functional action of FSH might be different in the mouse and human germ line since males with FSH-β mutations present with azoospermia [148] whereas homozygous FSH-β knockout mice had small testes and oligozoospermia but were fertile [4] . Only one LH-β gene mutation associated with male infertility has been reported [148] .
KALLMANN 1 (KAL-1) GENE LOCUS
The KAL-1 locus has been mapped to the X chromosome (Xp22.3) [149] [150] [151] . KAL-1 expression escapes X inactivation, has a putative non-functional homologue on the Y chromosome " Fig. (1) ", and shows an unusual pattern of conservation across species including Caenorhabditis elegans [152] . The predicted protein anosmin-1 plays a key role in the migration of Gonadotropin Releasing Hormone (GnRH) neurons and olfactory nerves to the hypothalamus and has significant similarities with other proteins involved in neural cell adhesion and axonal pathfinding, as well as with protein kinases and phosphatases. This supports that the KAL-1 gene could have a specific role in neuronal migration control [153] and that GnRH is a key regulator of reproduction and sexual behaviour.
KAL-1 mutations (intragenic deletions and point mutations) [154, 155] cause the pathology of Kallmann syndrome typically defined as an association between hypogonadotropic hypogonadism and anosmia, i.e. the inability to smell. Since it occurs more frequently in men (1:10000) than in women (1:50000) X-linked inheritance has been predicted (KAL-1) although also examples of dominant (KAL-2) and autosomal recessive (KAL-3) inheritance has been described ( Table 2) . Loss-of-function mutations in the fibroblast growth factor receptor 1 (FGFR1) gene located on the short arm of chromosome 8 (8p11-12) were identified recently as the molecular base of the dominant autosomal KAL-2 locus [156] . Since the KAL-1 and FGFR1 genes were found to be co-expressed at different sites during embryonic development a functional interaction between both proteins can be proposed. This would also explain the higher prevalence of Kallmann syndrome in males.
Genetically, Kallmann syndrome is therefore heterogenous and genotype-phenotype correlations are difficult to settle [157] . There is some evidence that KAL-1 gene deletions in Xp22.3 sometimes include also functional elements of other genes like of DAX-1 located in the neighbourhood of KAL-1. Since DAX-1 mutations cause hypogonadotropic hypogonadism associated with adrenal hypoplasia congenita (AHC) during infancy [158] , some patients with Kallmann syndrome and renal agenesis might present with KAL-1 gene mutations influencing the expression of the DAX-1 gene as well [159] . Kallmann syndrome is the most common X-linked disorder with male infertility. The patients can be treated usually successful by a hormone replacement therapy.
MALE INFERTILITY SYNDROMES WITH POLY-GENIC INHERITANCE PATTERN
The most prominent example where a male infertility syndrome is associated with mutations in different genes is the immotile cilia syndome: primary ciliary dyskinesia (PCD; OMIM no. 242650), also called Kartagener syndrome (KS; OMIM: 244400) when associated with situs inversus [187] . The prevalence of PCD is estimated with 1 in 20.000-60.000 but as KS it appears in a more frequent range between 1 in 8.000-25.000. Spermatozoa of men with the Kartagener syndrome (KS patients) are immobile like the cilia in their respiratory tract. Complete absence of dynein arms forming temporary cross brigdes between adjacent ciliary filaments could be demonstrated as causative agent. Dynein arms are believed to be responsible for generating movement in cilia and sperm tails. But the ultrastructural defects observed in KS patients are variable [161] and patients with the phenotype of Kartagener syndrome in somatic cells but no effects on sperm motility are also observed [162] . Although pedigree analysis mostly suggests an autosomal recessive inheritance pattern of KS, X-linked and autosomal dominant inheritance patterns are reported as well [163] . This points to genetic heterogeneity of the Kartagener syndrome, i.e., caused by mutations in multiple genes although of the same genetic network. A genome-wide linkage analysis has now confirmed the expected extensive locus heterogeneity for the PCD syndrome [164] and the first three genes causing Kartagener syndrome if mutated have been molecularly isolated: the gene encoding the dynein axonemal intermediate chain 1 (DNAH1) on the short arm of chromosome 9 (9p13-21) [165] , the gene encoding the dynein axonemal heavy chain 5 (DNAH5) on the short arm of chromosome 5 [166] , and the gene encoding dynein axonemal heavy chain 11 (DNAH11) on the short of chromosome 7 (7p21) [167] . The axoneme is composed of about 250 distinct proteins [168] . Therefore it can be expected that also mutations in the other dynein axonemal arm genes will cause a KS phenoytpe.
A polygenic inheritance patterns has been also discussed for the phenotype of round headed spermatozoa induced by malformations of the acrosome [169] . The number of roundheaded sperms can vary between 14 and 71 %. Two types of globozoospermia are distinguished: Type I is characterised by a complete lack of acrosome and acrosomal enzymes and by a spherical arrangement of the chromatin. These sperms are unable to penetrate the zona pellucida, causing infertility. Type II has some acrosomal activity covering a canonical nucleus surrounded by large cytoplasmic droplets [170] . Elevated chromosome aneuplodies were found in roundheaded sperms with FISH using probes for chromosomes 13, 15, 18, 21 , X, and Y [171, 172] , although this could not be confirmed by other authors [173, 174] . However, in all cases an increased damage of the sperm chromatin structure has been reported, indicating a high mutational load in the paternal DNA structure of these patients. Globozoospermic sperms will therefore have an inherent low fertilisation rate also with the ICSI protocol, because an increased damage of sperm chromatin and DNA is generally decreasing the sperms fertilisation capacity and also impair early embryonic development [175] .
INSL3 AND LGR8-GREAT GENE LOCI
INSL3/LGR8-GREAT are both functional involved in the molecular mechanism of testis descent. Testicular descent from abdomen to scrotum occurs in two distinct phases: the trans-abdominal phase and the inguino-scrotal phase. The gubernaculum connects the gonad to the inguinoscrotal region and is involved in testis descent. It rapidly develops in the male fetus, whereas development in the female fetus is lacking. Since absence of Insl3 in male mice resulted in bilateral impairment of testis descent, i.e., cryptorchidism [176, 177] it has been proposed that mutations involving this gene may be a cause of cryptorchidism also in men. Cryptorchidism is one of the most frequent congenital abnormalities in humans, involving 2% of male births (OMIM ref.: 219050). Cryptorchidism can result in infertility and an increased risk for development of germ-cell tumours. The aetiology of cryptorchidism is for the most part unknown and appears to be also genetically heterogeneous. Other factors involved in gubernaculum development are e.g. androgens and anti-Mullerian hormone (AMH).
In human, INSL3 has been mapped on chromosome 19 (19 p13.2) . It is also known as relaxin-like factor (RLF) and Leydig insulin-like protein (LEY I-L) and a member of the insulin/relaxin hormone superfamily that is highly expressed in Leydig cells. The frequency of INSL3/RLF gene mutations as a cause of cryptorchidism seem however to be low, because only 2 of 145 (1.4%) formerly cryptorchid patients were found to have a INSL3 mutation [178] . Mutation analysis of the coding regions of the INSL3 gene was performed in 145 formerly cryptorchid patients and 36 adult male controls using single-strand conformational polymorphism (SSCP) analysis. Two mutations, R49X and P69L, and several polymorphisms were identified.
INSL3 is the ligand for LGR8, one of the recently identified G protein-coupled orphan receptors (LGR4-8) homologous to gonadotropin and thyrotropin receptors [179] . Transgenic mice missing the LGR8 gene also displayed cryptorchidism. The same mouse gene but designated as GREAT (G-protein-coupled REceptor Affecting Testis descent) because identified by a different research group [180] was screened for some nucleotide variants in 61 cryptorchid human patients Comapred with theGREAT cDNA sequence a unique missense mutation (T222P) was identified in the ectodomain of the GREAT receptor [180] . Two sequence variants in exon 12 (A/G transversions at nucleotide positions 957 and 993) were identified in 40 out of the 61 cryptorchid patients but also in the normal control men displaying 3 different haplotypes (A957 and A993, A957 and G993, G957 and G993).
The low frequency of mutations found in the INSL3 and GREAT/LGR8 gene locus of patients with maldescent testes suggest that this frequent pathology must be caused also by mutations in some other genes. Indeed, some candidate genes were already indicated by chromosome analyses to be probably located on chromosome 1, 2, 8, 9, 22, X and the Y chromosome [181] .
DYSTROPHICA MYOTONICA (DM) LOCUS
Myotonic muscle dystrophy (DM) is a dominant inherited disorder in which the muscles contract but have decreasing power to relax. The major gene (DM-1 or DMPK) causing about 95% of the DM disease has been mapped on chromosome 19 (19q13.2-3) . Since the Nterminal domain is highly homologous to cAMP-dependent serine-threonine protein kinases, myotonin-1 has been recognised as a phosphorylation enzyme (called DMPK). Myotonic dystrophy is caused by mutations producing pathogenic RNA molecules that accumulate in nuclear foci because of an increased amplification of a CTG-repeat located in the 3´UTR of exon 15. Unaffected individuals have between 5 and 35 copies of the CTG-triplet, myotonic dystrophy patients who are minimally affected have at least 50 repeats, while more severely affected patients have an expansion of up to several thousand repeats. An unusual feature of this illness is that its symptoms usually become more severe with each successive generation (anticipation).
This disorder commonly occurs during young adulthood although it can occur at any age and is extremely variable in degree of severity. It can cause mental deficiency, hair loss, cataracts and infertility [182] . Patients with infertility and hypogonadism usually feature only mild somatic defects, although intellectual abilities are often in the low range. Similar to Kennedy disease, clinically relevant gonadal pathologies develops after puberty. Infertile DM patients present with testicular atrophy, loss of libido and of potency [183] . Comparing sperms´ capacitation and acrosome reactions in the ejaculates of infertile DM patients and healthy men by different diagnostic tools (like the Pisum sativum and D-mannose receptor expression assays), a complete lack of capacitation and acrosome reaction of sperms from the DM patients has been diagnosed [184] . These anomalies therefore most likely cause the infertility of DM patients. Obviously, ICSI is a therapeutic option for the infertility of DM patients because capacitation difficulties can be easily circumvented by this ART method. However, considering the dynamic expansion of the CTG-repeat in exon 15 of the DM-1 gene from one generation to the next, it is expected that the severity of the DM disease will be increased in the ICSI offspring. DM patients with male infertility asking for IVF/ICSI should therefore visit first a genetic counselling service who can evaluate the severity of the somatic DM risk factor based on the family pedigree.
DNA POLYMERASE G (POLG) LOCUS AND MITOCHONDRIAL DNA
The human POLG gene locus encoding the catalytic subunit of mitochondrial DNA polymerase has been mapped to the long arm of chromosome 15 (15q25) [185] . POLG is the only DNA polymerase responsible for mitochondrial DNA replication. The protein contains a polyglutamine tract encoded by a CAG repeat in the first POLG exon. This CAG repeat is polymorphic in length as found for the AR gene but with a much lower variability. In different ethnic populations the common ten-repeat allele is found with a uniformly high frequency (0.88) and absent in only 1% of the individuals [186] . This indicates in contrast to the AR-CAG repeat a strong positive selection for one major CAG 10 -allele.
In infertile men with moderate oligozoospermia a mutant genotype (absence of the common CAG 10 -allele; designated furtheron as "abs10" POLG-allele) has now been found at an elevated frequency in all populations studied [187] . Using sperm DNA from persons in whom azoospermia was excluded, 9 of 99 infertile males (9%) from Finland or England were found to be homozygous for the "abs10" POLG-allele. In contrast, this allele was present in sperm DNA from all 98 fertile males studied, as well as in all but 6 of 522 healthy controls, whose blood DNA was analysed in parallel. Based on standard Hardy-Weinberg predictions, the homozygous mutant genotype "abs10/abs10" should be found in approximately 1.7% of individuals, as was confirmed by Rovio and coworkers [187] . The frequent finding of the "abs10/abs10" genotype in infertile men (9.1%) is therefore highly significant. The POLG genotype in blood and sperm was similar in these individuals, thus excluding any effect of de novo tissue-specific mutations. A higher frequency of heterozygosity for the "abs10" allele in infertile males (35%) than in fertile males (18%) or in the general population (23%) also suggests a causative influence of this POLG allele on the men´s fertility [187] . Given the many rounds of cell division during spermatogenesis and the functional necessity of mitochondrial (mt)DNA for sperm function, it seems plausible that a suboptimal mitochondrial DNA polymerase could result in the accumulation of mtDNA mutations and in failure to complete differentiation. Thus the "abs10" POLG allele would be somehow deleterious to sperm differentiation but would have no obvious, phenotypic effects in other tissues.
The "abs10/abs10" POLG variant was found at an elevated frequency in men with moderate oligozoospermia in all populations studied. Their sperm quality was below the commonly accepted thresholds for at least 2 out of the 3 common parameters: sperm number (<20 million per ml), motility (<50% motile) or morphology (<10% normal morphology). The finding of a distinct POLG variant in men with moderate oligozoospermia indicates that, at least within European populations, the occurrence of this POLG variant contributes to about 5-10% of the cases with idiopathic male infertility.
It might be possible that the specific mtDNA replication function of POLG is probably also involved in the deleterious dynamic of the sperm mtDNA sequence. Sperm motility and other parameters of sperm quality appear to be generally correlated with the intactness of the mitochondrial DNA sequence (mtDNA) since in infertile males mtDNA deletions have been found at a larger scale [188] [189] [190] [191] . Recently, also an association between asthenozoospermia and a distinct mtDNA haplogroup T with some point mutations in mitochondrial t-RNAs was reported [192] . Asthenozoospermia contributes to male infertility in about 30% of all cases. All genes encoding components of the mtDNA maintenance machinery might therefore be regarded as candidates for being involved in male fertility. The motility of spermatozoa is also heavily dependent on the mitchondrial respiratory energy. An impaired energy metabolism of sperms has therefore long been hypothesized to contribute to infertility as well [193] .
To summarize, given the high number of putative human male fertility genes, mutations causing male infertility are easily identified if (1) the frequency of the mutation is high, as shown above for the AZFa-c and DAZ1/DAZ2 microdeletions and for the CFTR point mutations, respectively, or, if (2) it is possible to select a distinct patient subgroup out of the large and heterogenous idiopathic male infertility group by e.g. a specific clinical pathology like androgen insensitivity and cryptorchidism, or by a specific hormone profile or semen pathology as found with the Kallmann and Dystrophica myotonica syndromes.
A comprehensive mutation analysis of a given human male fertility gene will be technically always timeconsuming, unless one develops technologies based on chips with high-density oligonucleotide arrays of the gene in question. Another molecular approach with the advantage of studying multiple fertility genes in parallel would be a comparative analysis of the genes´ testicular expression profiles on appropiate chip matrices. These studies might be Comparison of RNA chip expression profiles from patients with spermatogenic disruptions at different phases would be then the first step towards a molecular insight in the genetic network controlling human spermatogenesis.
MALE INFERTILITY AS A PLEIOTROPIC MUTA-TION EFFECT OF SOMATIC DISEASES
Multiple somatic genetic disorders cause male infertility pleiotropically ( Table 2) . That means that patients with mutations in e.g. the DM-1 gene causing myotonic dystrophy are not always infertile (see above). Considering different cell systems, the primary effect of a gene mutation is not always identical and only sometimes but not always (i.e. pleiotropically) a second pathology occurs in an apparantly remote cell system. This is because of the individual pattern of heterozygous mutations in the other genes which are not visible because of the lack of distinct phenotypes but which share the same genetic control circuit. This individual specific "heterozygosity" is also called "genetic load factor". It also explains why an observed mutant phenotype does not always follow the normal Mendelian rules [194, 195] . According to these rules, recessive and dominant mutations can usually be distinguished in the pedigree by the frequency of the observed pathologies. For pleiotropic gene mutations this is often doubtful as a recessive somatic gene defect linked to male infertility can have a dominant inheritance pattern in the germ line like shown for the CF/CBAVD locus (see above). It is therefore also not surprising when the same mutation in a given gene locus (e.g. AR, CFTR, FSHR) cause a variable pathology or sometimes only display male infertility as a single pathology.
HUMAN SPERMATOGENESIS PHASE MARKER GENES
If one wants to identify some patient subgroups with disruptions at specific phases of spermatogenesis, a detailed and comparative registration of all molecular clinical data in a personal patient database is an essential prerequiste. In the past this usually includes, besides a detailed description of the patients´ hormone profiles and semen parameters, also a detailed histological description of the observed testicular damage. Now, it is possible to improve these classification criteria significantly by the analyses of the testicular expression profiles of some spermatogenic key genes, i.e., of genes which are known from basic research to control spermatogenesis at different phases [196] . Such "spermatogenesis phase marker genes" are e.g. DAZL1 for diagnosing the presence of premeiotic germ cells [197] , CREM for diagnosing the expression of postmeiotic spermatids [198] and CDY1 for diagnosing the putative presence of mature spermatozoa in the patient´s testis tissue [199] . Although formal proof is still missing that these genes are functional required in human spermatogenesis (no gene mutations associated with male infertility are known), the transcriptional and translational activities of these key genes are also most valuable for an evaluation of the residual functional capacity in the patient´s germ line. With these data in the clinical patient data base, it is then also possible to predict much better the presence of some mature spermatozoa in the patient testis tubules; This is of upmost clinical importance for all cases of male infertility where a successful testicular sperm extraction (TESE) is needed as a prerequiste for successful ICSI treatments. The expression pattern of some hormone levels, FSH, LH, Prolactin, Testosterone, and also inhibin B, in the infertile men are not predictive for these practical aspects [200, 201] .
DAZL1 Expression is Diagnostic for the Presence of Germ Cells
A master control gene for premeiotic germ cell development is the DAZL1 gene encoding a male and female germ line specific RNA-binding protein [202] . It is with the BOULE gene a member of the Y chromosomal DAZ gene family in the AZFc locus (Table 1A) . Howver, in contrast to DAZ, the BOULE and DAZL1 genes are found highly conserved with homologues in vertebrates (mouse: boule and Dazl1; Xenopus: Xdazl; zebrafish: zdazl) and invertebrates (Drosophila: boule, Caenorhabitis elegans: cdazl) [203] . The boule gene is found in flies and human. It can therefore be designated as the ancestor of the DAZ gene family which then amplified first from boule to Dazl in vertebrates, then from Dazl to DAZ in primates. This genomic amplification process has been probably triggered by a functional essential extension or an increased requirement for the function of these testicular RNA binding proteins in the different species classes [203, 204] .
The presence of DAZL1 transcripts and proteins is diagnostic for the presence of germ cells in the patientst esticular tissue samples. It is therefore not surprising that any impairment of the spermatogenic process can be visualised by a moderate till severe reduction of DAZL1 gene products [197] . Since DAZL1 mRNAs have been also found in the semen fluid [205] a quantitative RT-PCR analyses of DAZL1 gene expression is possible without any invasive clinical treatments and can be included in the normal andrological semen quality workup. Using polyclonal antisera raised against a specific DAZL1 peptide it has been shown that DAZL1 proteins are accumulating in the midpiece of mature spermatozoa [205] . Absence of DAZL1 gene products are therefore also indicative for the absence of spermatozoa in the patient´s testicular tissue. Since also DAZ proteins have been found to accumulate in late spermatids and human sperm tails " Fig. (6) " [206] it can be assumed that the functional activities of the multiple DAZ genes in human spermatogenesis significantly exceeds beyond the function of the single DAZL1 gene in mouse spermatogenesis. 
CREM Expression is Diagnostic for the Presence of Postmeiotic Germ Cells
The CREB/CREM transcription factors are expressed in germ cells and Sertoli cells in a circidian fashion dependent on cAMP signaling induced by the pituitary gonadotropic hormones FSH and LH [207] . By alternative promoter usage and alternative exon splicing events different CREB/CREM protein products are translated which function as transcriptional activator or repressor for distinct target genes. CREB is poorly expressed in testis. CREM is expressed at very high levels and therefore thought to be a master regulator of the male germ cell along its whole pathway. Most of the CREM target genes still need to be identified (see e.g.: http://www.dkfz-heidelberg.de/tbi/crem/). They are recognised by the presence of a c-AMP-responsive element (CRE) in their promoter regions generally serving as binding site for the CREB/CREM transcription factors. Promiment examples are the genes encoding transition protein-1 (Tp-1), protamine-1 (Prm-1) and protamine-2 (Prm-2) which are specific structural components of the postmeiotically maturating sperms.
In human, the CREM gene has been mapped to the short arm of chromosome 10 (10p12.1-p11.2) [208] . It spans about 85 kb of genomic DNA and contains 14 exons encoding different functional domains " Fig. (7A) ". These are spliced together in a variable fashion after transcription from four different promoter sites (P1-P4) creating multiple mRNA lengths. Additionally FSH appears to regulate CREM expression by alternative polyadenylation resulting in a dramatic enhancement of CREM transcripts stabilities [209] . Transcripts starting from P1 and including the Q-rich transactivation domains exon C (τ1) and/or G (τ2) encode CREM activator proteins for the postmeiotic germ cell transcription [209] . CREM τ mRNA expression in the cytoplasm of round spermatids therefore indicates postmeiotic germ cell differentiation. Expression of only the CREM repressor isoforms, α, β, γ in pachytene spermatocytes is indicative for a meiotic arrest of the patient´s spermatogenesis [210] .
Other testis-specific CREM isoforms with activating functions are those which include the θ1 and θ2 exons " Fig.  (7A) ". These CREM transcripts are starting from the P3 and P4 promoter [211] . Transcription from the c-AMP-inducible intronic P2 promoter gives rise to the ICER (Inducible-c-AMP-Early-Repressor) products, which are truncated CREM proteins containing only their C-terminal Basic Region (BR) and the two DNA-binding Domains (DBD I and II). ICER proteins binds to CRE elements and therefore are able to repress the activity of the own P2 promoter constituting a negative autoregulatory loop [212] . Most interesting, the testis-specific CREM activating function is not controlled by a protein kinase mediated phosphorylation step but through the physical and functional association between the activation domain of CREM and ACT (activator of CREM in testis), a LIM-only protein with coactivator properties expressed only in testis tissue [213] .
Diagnostic for the presence of postmeiotic germ cells in the patient´s testis tissue would be a comparative expression analysis of the activating CREM isoforms θ1, θ2 and τ mRNAs in the testicular tissue of men with normal spermatogenesis and of men with undefined spermatogenic arrest. RT-PCR experiments diagnostic for the presence of CREM τ1 mRNA with primer pairs spanning exon C encoding the τ1 activation domain " Fig. (7A) ", have been performed by Peri and coworkers. CREM τ1 mRNA transcripts were indeed only identified when postmeiotic germ cells have been found in the patient´s ejaculate [210] . A parallel analysis of the premeiotic CREM repressor transcripts α, β, and γ served as the internal control. Similar diagnostic RT-PCR experiments have been also performed for the identification of the other exons encoding the activating domains τ2 (exon G) and exon θ1 or θ2, respectively [198, 211] . Two CREM activator transcripts including the τ2 domain with and without the γ exon " Fig.  (7A) " have been identified in testis tissue RNA samples, but surprisingly not any CREM transcripts including exon C with the τ1 domain as was found by Peri et al. [210] have been registered [198] .
With annother set of exon probes multiple testis RT-PCR products prepared with primers specific for exon θ1, θ2 and the antisense primer from the 3´UTR in exon Ib, were identified " Fig. (7B) ". They include exon θ1 or θ2 respectively, E, F, G, H, and Ib but lack exon C and exon Ia. RT-PCR-experiments diagnostic for the presence of postmeiotic germ cells in testicular tissue or semen fluid should therefore focus on the identification of CREM τ2 and θ1 or θ2 transcripts because these seem to be more prominent than CREM τ1 transcripts. If this simple diagnostic CREM RT-PCR-assay would work also routinely on RNA samples from semen fluid, it would be extremely valuable in all cases of idiopathic male infertility were the tissue sample is too small for a parallel CREM τ mRNA analysis and where multiple TESE are needed for the isolation of single sperms.
This CREM RT-PCR analysis can be corroborated with a CREM protein analysis in the patients´ testicular tissue sections. The CREM protein is only present in the spermatids if the patient´s spermatogenesis proceeds through the round spermatid phase [214, 198] . Further analysis for the expression of CREM downstream genes like the TP-1, PRM-1 and PRM-2 genes would be able to pinpoint the postmeiotic arrest phase of the patient´s spermatogenesis then in detail [215] .
CDY1 Expression is Diagnostic for the Presence of Mature Sperms
Besides the expression of the protamine-2 gene [216] also expression of the CDY1 gene [199] is a useful molecular marker to predict the presence of testicular sperm in patients with nonobstructive azoospermia. The CDY1 gene locus was mapped in the AZFc deletion interval of the human Y chromosome (Table 1A) . It is a member of the CDY gene family with more copies in and proximal to the AZFb deletion interval (CDY2) [69] and on chromosome 6 (CDYL) [85] . CDY1 and CDY2 are retrotransposed mRNAs from the CDYL gene evolved during primate evolution. Only the CDY1 gene have evolved then furtheron a two exon gene structure from which 4 alternative spliced transcripts encoding 3 different protein isoforms have been already documented " Fig. (8) ". Only the major CDY1 transcript is identical in sequence to the CDY2 transcript [85] . CDY2 and all CDY1 isoforms are nuclear proteins with a N-terminal chromo-domain recently identified as histone acetyltransferases with a strong preference for histone H4 [217] . The proteins have been localised in the nuclei of maturing spermatids. At this spermatogenic phase, H4 hyperacetylation takes place during the histone-to-protamine transition of the postmeiotic chromatin condensation process in the rat male germ line [218] . Histone hyperacetylation results in a more open chromatin structure which facilitates not only the spermatogenic histone replacement but also provides an easier access of transcriptionally regulatory proteins like the CREM transcription factors to the postmeiotic sperm DNA. With the use of specific primer pairs for transcripts of the CDY1 and CDY2 genes it has been shown that the spliced minor CDY1 mRNAs " Fig. (8) " are both diagnostic for the presence of mature germ cells [199] . Expression analysis of the CDY1 minor transcripts in testicular tissue or semen fluid is therefore useful to identify the completeness of the patients´spermatogenesis.
AZF-DNA Deletions are Diagnostic for the Absence and Presence of Mature Sperms
A molecular analysis for AZF DNA deletions in the Y chromosome of azoospermic men is an attractive prognostic tool for the finding of mature sperms in the patient´s testis tissue without the need of testicular gene expression analyses. Since it has been shown that patients with a complete AZFa or AZFb deletion usually suffer from a complete absence of germ cells (AZFa) or a complete absence of postmeiotic germ cells (AZFb), clinical testicular sperm extractions (TESE) for ICSI treatment are not recommended for these patient groups, because these are usually not successful [61, 219] . However, if a partial or complete AZFc deletion has been diagnosed in the patient´s Y-DNA, testicular mature sperms are often found in single testis tubules because a residual local complete spermatogenesis is typical for this large patient group including the frequent presence of single sperms already in the patient´s ejaculate (cryptozoospermia). Important is however to stress, that only complete AZFa and AZFb deletions will have this predictive power. Therefore, if deletions have been identified in AZFa or AZFb, they must be also analysed for their molecular extensions as described in the literature [56, 69, 220, 221] .
MALE FERTILITY MARKER GENES
Mature mammalian spermatozoa require a post-testicular maturation process, including their exposure to the specific microenvironment provided by the epididymis. Therefore ICSI fertilisation rates with testis extracted spermatozoa (TESE) are usually lower then with mature spermatozoa isolated from the patient´s ejaculates [222, but see also 223]. Also a reduced implantation rate has been reported for ICSI cycles with testicular sperms compared with those using ejaculated sperms [224, 225] . Thus, there is ample circumstantial evidence that the epididymis function is essential for male fertility and that epididymal proteins are involved in this process [226] . However, our understanding of how the individual proteins implement the acquisition of sperm fertilizing ability is still fragmentary. In order to better appreciate the role of the epididymis at a molecular level, a careful analysis of its specific pattern of gene expression needs to be elaborated [227] . In any case, a diagnosis of the Fig. (7) . A. Schematic view on exon structure of the human CREM locus according to Gellersen et. al. [2002] . The exact lengths for the θ1, θ2 and τ1 exons are given only preliminary. Since CREM transcripts are found to be promoted from four different promoter sites (P1, P2, P3, P4), different CREM proteins are expected. The variability of their encoding open reading frames (ORFs) are indicated by the shadowed exon regions starting at four different initiation sites marked with an ATG and ending at three different STOP sites. CREM transcripts starting from P1, P3, P4 include the Q-rich transactivation domains in exon C and G, respectively, exon θ1 and θ2. The P2 promoter contains an c-AMP inducible CRE element. Therefore CREM proteins of transcripts starting from P2 and only encoding the DNA binding regions DBD-I and DBD-II are functioning as repressors (ICER proteins) for the same promoter site constituting a negative autoregulatory loop. B. Expression of CREM splicing variants containing exon θ1 and θ2 in 2 different human testis RNA samples. Prominent CREM RNA variants are already visible after Ethidium-bromide (EtBr) staining of the RT-PCR products in the agarose gels (on the left). More variants are visible after hybridising corresponding blots with specific exon probes as indicated. Marker lengths are given at the left. For further discussion of these results see text.
fertility potential of a semen sample is essential and beyond the analysis of spermatogenesis phase marker genes. Accurate molecular genetic diagnostic tests to determine the sperm´s fertility potential are therefore strongly recommended.
PHGPx Expression as Male Fertility Marker
A prominent male fertility marker protein already expressed in spermatids and then located as major structural protein in the midpiece of sperm tails is the mitochondrial capsule selenoprotein (MCS) encoded by an isoform of the Gluthathion peroxidase gene GPX-4 [228] , which is located on the short arm of chromosome 19 (19p13.3) [229] . The GPX-4 isoform encodes the phospholipid hydroperoxide glutathione peroxidase (PHGPx) enzyme expressed in three different forms using alternative start codons. These target the enzyme to the cytosol, mitochondria, or to the nucleus, respectively. Preferential PHGPx gene transcription is observed in the late round spermatids, but ceases then abruptly upon transition to elongated spermatids. The change in shape from round spermatids to the elongated forms timely parallels the change of the chromosomal packaging proteins from histones to protamines. PHGPx activity in spermatids may therefore also functionally contribute to crosslinking of the protamine thiols which is essential for stabilisation of the postmeiotic condensation of sperm chromatin.
In mature spermatozoa PHGPx activity is hardly detectable because it has been transformed to the oxidatively inactivated MCS protein [228] . This switch in the redox status during late sperm maturation is explained by a disappearance of GSH, the usual PHGPx reductant. PHGPx, thus deprived of its usual GSH reduction, becomes crosslinked with itself and with other SH-proteins via selenodisulfide bridges. In the midpiece of mature spermatozoa, the oxidised PHGPx protein represents at least 50 percent of the capsule material that embeds the helix of mitochondria. The mechanical instability of the mitochondrial midpiece that is observed after selenium deficiency also points to an essential role of PHGPx as a structural sperm tail protein.
The PHGPx protein content in sperms can be estimated after reductive solubilization by measuring the rescued PHGPx activity [230] . It was found that the rescued PHGPx activity in infertile men ranged significantly below that of controls (93.2 ± 60.1 units/mg sperm protein vs. 187.5 ± 55.3 units/mg). It was particularly low in oligoasthenozoospermic specimens (61.93 ± 45.42 units/mg; P < 0.001) compared with controls and asthenozoospermic samples. In isolated motile samples, motility decreased faster with decreasing PHGPx content. Obviously, irrespective of the cause of alteration, the content of PHGPx in spermatozoa is correlated with fertility-related parameters and their residual PHGPx protein activities can be used as a predictive marker for the patients´ sperms remaining fertilization capacity.
PRM-1/PRM-2 Expression and Sperm Chromatin Condensation as Male Fertility Markers
Male infertility can be also associated with abnormal sperm chromatin condensation due to a lack of protamines [231] . Protamines are the major DNA-binding proteins in the nucleus of sperms in most vertebrates, packaging the DNA in a volume less than 5% of a somatic cell nucleus. Many mammals have one protamine, but a few species, including humans and mice, have two. Mouse knock-out studies for both protamine genes have now shown that they are functional not redundant but that both protamines are essential for sperm chromatin condensation and that haploinsufficiency caused by a mutation in one allele of Prm-1 or Prm-2 prevents genetic transmission of both mutant and wild-type alleles [232] . It has now been shown in mice experimentally that protamines are indeed essential for Fig. (8) . Schematic view on CDY1 locus in AZFc. The transcription of this CDY gene copy in human testis produces at least four alternative spliced mRNAs published with the following GenBank accession numbers: CDY1 major-a (AF080597), CDY1 major-b (BC033041), CDY1 minor (NM004680) and CDY1 minor-short (this variant was identified by Kleiman et al. 2001 and is not deposited in the GenBank). Both minor variants spliced out an intron sequence from the CDY1 exon at two different 5´ splicing sites but with identical 3´splicing sites. This results in an alternative two-exon structure of the CDY1 gene and the translation of 3 protein isoforms. Their variable coding frames are marked with below the different transcript lengths given in numbers of nucleotides without the poly(A) tail. The variable 5´ intron part is marked with .
compaction of the sperm nucleus and COMET assays have demonstrated that there is a direct correlation between the fraction of sperm with haploinsufficiency of Prm-2 and the frequency of sperm with damaged DNA [233] . As expected, ultrastructural analysis revealed reduced compaction of the sperm chromatin. ICSI with Prm-2-deficient sperms result in activation of most metaphase II-arrested mouse eggs, but only few were able to develop to the blastocyst stage. These findings suggest that the integrity of sperm DNA is also important for early embryonic development which fails if there is an increased damage of sperm DNA. Prm-2 protein is therefore one of the crucial gene products for maintaining the integrity of sperm chromatin.
Prm-2 deficient sperms have also reduced amounts of Prm-1 indicating that Prm-1 requires the normal amount of Prm-2 to become incorporated into sperm chromatin. These results raise the question whether also in human the ratio of protamine 1 (PRM-1) and protamine 2 (PRM-2) expression in the testis tissue can be a reliable prognostic marker, not only for the integrity of sperm chromatin and male fertility, but also for normal early embryonic development after fertilization. Abnormal sperm protamine levels are a common defect in infertility patients [173, 234] but ICSI fertilization and subsequent embryo cleavage have been found to be not different in patients without PRM-2 protein expression in sperms, although general effects of sperm nuclear DNA damage and altered chromatin structure on fertilization and embryo development have been reported [176] . All patients should therefore offered an analysis of the integrity of chromatin and DNA in the sperms especially if they suffer from a known mitochondrial disease or if the sperms are globozoospermic [175] . For this purpose a ubiquitin-based sperm quality assay has been developed recently [235] , since it was found that morphologically bad sperms have been tagged by ubiquitin during their epididymal passage [236] .
THERAPEUTIC PERSPECTIVES FOR TREATMENT OF GENE DEFECTS CAUSING HUMAN MALE INFERTILITY
Therapeutic concepts for the treatment of gene defects causing male infertility are still rare. The only examples are hormone replacement therapies in patients with a clinical picture of idiopathic hypogonadrotopic hypogonadism (IHH syndromes) where the primary defect and reason for their infertility have been diagnosed in the hypothalamus or puitrary (e.g. Kallman syndrome; Reifenstein syndrome). Spermatogonia stem cells have the capacity to rejuvenate spermatogenesis after toxic insult in animal models. In principle, it should therefore be possible to re-initiate the spermatogenesis cycle in a man with severe infertility, independent from a genetic aetiology, as long as one is able to identify a spermatogonial stem cell in his testis tubules. A general therapeutic concept for all men which still have some stem cell spermatogonia in their testis tubules should therefore be possible [237] . However, first interspecies cross experiments with spermatogonia stem cells of macaques transferred to the empty testis tubules of a fertile rat displayed an interruption of the spermatogenesis cycle shortly after meiosis [238] . Molecular reasons for this draw back are most likely the rapid evolution rates of genes that are involved in the postmeiotic reproduction cycle [239] . Comparing 2.820 rodent genes with their homologous human genes, reproductive genes are found among the 10% most divergent sequences [48] . Postmeiotic maturation of the spermatogonia might therefore be only possible in the patient´s own or in a human donor germ line.
SHOULD THERAPEUTIC CONCEPTS TREATING MALE INFERTILITY BYPASS THE GENETIC DEFECT?
It has become popular to bypass the patient´s male infertility by using the ICSI protocol also after a genetic defect has been diagnosed causing the patient´s infertility. However, recent descriptions of an increased rate of chromosome abnormalities in ICSI offspring [39] and a twice as high risk for major birth defects in IVF/ISCI offspring when compared with naturally conceived infants reported in a large Australian study [240] now put a serious question mark behind this practical decision.
A major concern is the largely unknown risk of transmitting not only the genetically caused male infertility to the ICSI offspring, but also some of the pleiotropic genetic syndromes discussed above with unpredictable somatic pathologies, because of the unknown "genetic load factor" of the ICSI embryo. One example which has been described in this review are the individuals with AZFc deletions which did display severe gonadal dysgenesis [107] .
Another major concern are the safety aspects of ICSI and other ART protocols for the epigenetic control program of the human preimplantation embryo which is not yet well understood [241] . There is now first evidence that the disproportionate high number of low birth weights in offspring of assisted reproductive technology is not due to the higher rate of multiple gestations associated with ART but most likely due to imprinting defects [242] . The authors compared in their study only singletons: 42.463 infants who were born with ART and 3.389.098 infants born naturally. They found a significant increase of a low birth weight in the ART infants and this low-birth rate did not increase when comparing twins in both study groups.
Gene specific imprinting defects during fetal development, especially the occurrence of Angelman syndrome (AS), were reported recently to be associated with infants born after ICSI treatment [243] . AS (OMIM ref. No. 601623 ) is a neurogenetic disorder characterised by severe mental retardation, delayed motor development, poor balance and absence of speech. It is caused by loss of function of the maternal allele of the UBE3 gene located on chromosome 15. The paternal allele is usually imprinted by methylation [244] . In both cases, exon 1 of the SNRPN gene which is part of the regulating imprinting center (IC) in this chromosome region (OMIM ref. No. 182279) was found to be hypomethylated [243] . Usually, AS is a rare disease (1:15.000 newborns) and imprinting defects account for only about 5% of all cases, i.e., after natural reproduction the incidence of a maternal methylation, as found in both ICSI cases, is usually not higher than 1:300.000. This suggests an over-representation of AS imprinting defects among children conceived by ICSI [243] . Both AS infants were conceived by a couple who sought ICSI because of the men´s oligozoos-permia, which in one case was associated with a decrease of sperm motility and in the second case with hypogonadotropic hypogonadism. The pregnancies were uncomplicated.
A second imprinting disease probably also associated with ART was found with the Beckwith-Wiedemann syndrome mapped on the short arm of chromosome 11 (11p15:; BWS: MIM no 130650) [245] . The authors report of 6 children with BWS which have been born after ICSI. Five of them showed an abnormal imprinting (hypomethylation) of the LIT1 RNA within the K v LQT1 gene locus (OMIM ref. no. 192500) , one an abnormal imprinting (hypermethylation) of H19 RNA which controls the activation of the IGF2 gene [245] . In contrast to the Angelman syndrome, BWS is mainly caused by loss of imprinting (LOI) making it more difficult to postulate a causal relationship between ART and the occurrence of BWS. However, on the basis of a national BWS registry established by the authors in 2001, a six-fold increase of BWS in children born after ART, compared with the BWS rate in the general population, was estimated.
Since in both, AS and BWS ICSI infants, the maternal allele was affected, these imprinting defects seem to be not caused by some sperm defects but by some unknown disturbations of the maternal genome in the maturating oocyte or after the cytoplasmic injection of the sperm according to the ICSI protocol. One known causative agent impairing in vitro oocyte development are obviously suboptimal culture conditions used for the maturating oocytes, since differential effects of culture conditions on imprinted genes of the mouse preimplantation embryo have been reported [246] . However, in order to confirm or falsify the proposed ART-linked imprinting defects in IVF embryos a larger group of ICSI offspring needs to be studied for similar imprinting defects. For this purpose introduction of a prenatal methylation test for imprinted gene loci in all embryos conceived by ICSI might be required.
